Drug Patent Linkage & Drug Patent Term Extension – Current Situation Around the World (RECORDING)

China has recently introduced much anticipated drug patent linkage measures as part of its implementation of IP reforms required by the U.S.—China Phase I Trade Agreement. This webinar will introduce details of this system. Panelists will describe how it works, share views on whether it is likely to be effective, and provide updates on the latest developments in actions that have been brought under it. They will also discuss the drug patent linkage system of South Korea and provide a comparison with U.S. patent linkage measures.

Webinar Sponsored by Tee & Howe IP Attorneys

Jaeyoung Im

Patent Attorney & IP Head

Voronoi Inc.

Jaeyoung IM is a patent attorney and works as IP head at VORONOI, a pharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs. He leads the IP team of VORONOI, particularly, manages the company's global IP portfolio through strategic patent prosecution and litigation, and handles IP related agreements. So far, he worked on a number of open innovation agreement deals including license agreement deals with global pharmaceutical companies. Mr. IM majored in chemical and biological engineering at Seoul National University. He began his IP career at KIM & CHANG, which is a tier 1 law firm in South Korea, as a patent attorney in the chemical/pharmaceutical department. He also worked at JunHe Law firm in Shanghai as a visiting attorney from 2017 to 2018. Mr. IM’s practice focuses on a wide range of intellectual property matters including patent prosecution, litigation, enforcement, and transaction.

Toby Mak

Patent Attorney

Tee & Howe Intellectual Property Attorneys

Toby Mak is a patent attorney at the Beijing-based IP law firm Tee & Howe. He has substantial experience in both contentious and non-contentious matters, including those relating to prosecution, invalidation, and enforcement. He is one of the authors of "Patent Law in Greater China," published with the EPO. He has a Ph.D. in Chemistry and has served many clients in different technical fields including power tools, semiconductors, adhesives, and video-on-demand. He is also an active member of IPO’s Asian Practice committee.

Corey Salsberg

Vice President and Global Head of IP Affairs

Novartis

Corey Salsberg is Vice President and Global Head of IP Affairs for Novartis, a global healthcare company headquartered in Switzerland. He develops and advocates for the company’s policy positions. Prior to joining Novartis, Corey was an IP litigator in private practice.

Key:

Complete
Failed
Available
Locked
Drug Patent Linkage & Drug Patent Term Extension – Current Situation Around the World (RECORDING)
Open to view video.
Open to view video.
Evaluation Survey
12 Questions
CLE Credit
4 Questions
4 Questions CLE credit will be available for registered attendees only. If you would like CLE credit for this webinar, please complete the following questions. IPO will apply for CLE for all live programs in the majority of the states that require CLE. IPO will not be applying for CLE in the states of Florida, Ohio, South Carolina, West Virginia, or Texas (attorneys in TX may submit up to 5 hours of self-study credit). Once IPO has received approval from the state(s) CLE boards , certificate(s) of attendance will be available for download from your dashboard.
CA Certificate of Attendance
Up to 1.00 CLE credits available  |  Certificate available
Up to 1.00 CLE credits available  |  Certificate available California has approved this course for 1 hour of CLE credit. Only registered attendees that viewed this course are eligible to claim credit. To claim your credit, select "Claim Credit" then "View/Print Certificate" for your records.
IL Certificate of Attendance
Up to 1.00 CLE credits available  |  Certificate available
Up to 1.00 CLE credits available  |  Certificate available Illinois has approved this course for 1 hour of CLE credit. Only registered attendees that viewed the course are eligible to claim credit. To claim credit, select "Claim Credit" then "View/Print Certificate" for your records.